Literature DB >> 2701860

Costs of acute bacterial foodborne disease in Canada and the United States.

E C Todd1.   

Abstract

Bacterial foodborne disease is increasing in industrialized as well as developing countries. For Canada and the United States many millions of cases are believed to occur each year, based on extrapolations of survey data, human enteric isolations and reported foodborne disease cases. The economic impact of such a large number is probably in billions of dollars but the precise figure is difficult to calculate. Medical costs and lost income are easier to determine than losses to food companies, legal awards and settlements, value of lost leisure time, pain, grief, suffering and death. The evaluation of costs at the national level for Canada and the United States based on all available costs for 61 incidents showed that company losses and legal action are much higher than medical/hospitalization expenses, lost income or investigational costs. It was reckoned that on an annual basis an estimated 1 million cases of acute bacterial foodborne illness in Canada cost nearly $1.1 billion and 5.5 million cases in the United States cost nearly $7 billion. The value of deaths was a major contributor to the overall costs especially for diseases like listeriosis, salmonellosis, Vibrio infections, and haemorrhagic colitis. Salmonellosis is the economically most important disease because it affects all parts of the food system, unlike typhoid fever and botulism, which are largely controlled by public health authorities and the food industry.

Entities:  

Mesh:

Year:  1989        PMID: 2701860     DOI: 10.1016/0168-1605(89)90099-8

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  23 in total

1.  Simultaneous detection of Salmonella strains and Escherichia coli O157:H7 with fluorogenic PCR and single-enrichment-broth culture.

Authors:  V K Sharma; S A Carlson
Journal:  Appl Environ Microbiol       Date:  2000-12       Impact factor: 4.792

2.  Comparison of methods of extracting Salmonella enterica serovar Enteritidis DNA from environmental substrates and quantification of organisms by using a general internal procedural control.

Authors:  M M Klerks; A H C van Bruggen; C Zijlstra; M Donnikov
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

3.  Estimating the burden and cost of infectious intestinal disease in the Maltese community.

Authors:  C Gauci; H Gilles; S O'Brien; J Mamo; I Stabile; F M Ruggeri; N Calleja; G Spiteri
Journal:  Epidemiol Infect       Date:  2007-02-21       Impact factor: 2.451

4.  Chitin-induced carbotype conversion in Vibrio vulnificus.

Authors:  Jana Neiman; Yunzhi Guo; Dean A Rowe-Magnus
Journal:  Infect Immun       Date:  2011-06-13       Impact factor: 3.441

5.  Enterotoxigenic potential of Staphylococcus intermedius.

Authors:  K Becker; B Keller; C von Eiff; M Brück; G Lubritz; J Etienne; G Peters
Journal:  Appl Environ Microbiol       Date:  2001-12       Impact factor: 4.792

6.  Salmonella enterica diversity in central Californian coastal waterways.

Authors:  Sarah P Walters; Narjol González-Escalona; Insook Son; David C Melka; Lauren M Sassoubre; Alexandria B Boehm
Journal:  Appl Environ Microbiol       Date:  2013-04-26       Impact factor: 4.792

7.  The Proline Variant of the W[F/L/M][T/S]R Cyclic Di-GMP Binding Motif Suppresses Dependence on Signal Association for Regulator Function.

Authors:  Daniel M Chodur; Linda Guo; Meng Pu; Eric Bruger; Nico Fernandez; Chris Waters; Dean A Rowe-Magnus
Journal:  J Bacteriol       Date:  2017-09-05       Impact factor: 3.490

8.  Comparative genome analysis of Vibrio vulnificus, a marine pathogen.

Authors:  Chung-Yung Chen; Keh-Ming Wu; Yo-Cheng Chang; Chuan-Hsiung Chang; Hui-Chi Tsai; Tsai-Lien Liao; Yen-Ming Liu; Hsiang-Ju Chen; Arthur Bo-Ting Shen; Jian-Chiuan Li; Teh-Li Su; Chung-Ping Shao; Chung-Te Lee; Lien-I Hor; Shih-Feng Tsai
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

9.  Identification of a Wzy polymerase required for group IV capsular polysaccharide and lipopolysaccharide biosynthesis in Vibrio vulnificus.

Authors:  Alina Nakhamchik; Caroline Wilde; Dean A Rowe-Magnus
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

10.  Cyclic-di-GMP regulates extracellular polysaccharide production, biofilm formation, and rugose colony development by Vibrio vulnificus.

Authors:  Alina Nakhamchik; Caroline Wilde; Dean A Rowe-Magnus
Journal:  Appl Environ Microbiol       Date:  2008-05-16       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.